---
title: LOTTE Biologics vs Scinai Immunotherapeutics Ltd.
slug_a: lotte-biologics
slug_b: scinai-immunotherapeutics
site: cdmo
review_signal_gate: closed
canonical_path: /compare/lotte-biologics/scinai-immunotherapeutics
---

# LOTTE Biologics vs Scinai Immunotherapeutics Ltd.

Side-by-side profile data from each company listing on this directory.

## LOTTE Biologics

- Profile: [/companies/lotte-biologics](/companies/lotte-biologics)

LOTTE Biologics — LOTTE Biologics offers biologics CDMO services spanning process and analytical development, antibody manufacturing from clinical to commercial GMP, and bioconjugate manufacturing. Its operations are based at campuses in Syracuse, New York and Songdo, Incheon.

Services: 7. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Bioconjugation Services
- Process Development
- CMC Analytical Development
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)

## Scinai Immunotherapeutics Ltd.

- Profile: [/companies/scinai-immunotherapeutics](/companies/scinai-immunotherapeutics)

Scinai Immunotherapeutics Ltd. — Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.

Services: 6. Modalities: 1. Indications: 3. Locations: 2. Certifications: 2. The strongest documented coverage currently appears in services (6).

### Services

- Biologics Development & Manufacturing
- Recombinant Protein Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian